Search Results
Search for other papers by Christian Hölscher in
Google Scholar
PubMed
Introduction The main hallmark of type 2 diabetes mellitus (T2DM) is insulin desensitisation. The discovery that the incretin hormone glucagon-like peptide 1 (GLP-1) facilitates insulin release during episodes of hyperglycaemia and has several
Search for other papers by Qiaoli Cui in
Google Scholar
PubMed
Search for other papers by Yijing Liao in
Google Scholar
PubMed
Search for other papers by Yaojing Jiang in
Google Scholar
PubMed
Search for other papers by Xiaohang Huang in
Google Scholar
PubMed
Search for other papers by Weihong Tao in
Google Scholar
PubMed
Search for other papers by Quanquan Zhou in
Google Scholar
PubMed
Search for other papers by Anna Shao in
Google Scholar
PubMed
Search for other papers by Ying Zhao in
Google Scholar
PubMed
Search for other papers by Jia Li in
Google Scholar
PubMed
Search for other papers by Anran Ma in
Google Scholar
PubMed
Search for other papers by Zhihong Wang in
Google Scholar
PubMed
Search for other papers by Li Zhang in
Google Scholar
PubMed
Search for other papers by Zunyuan Yang in
Google Scholar
PubMed
Search for other papers by Yinan Liang in
Google Scholar
PubMed
Search for other papers by Minglin Wu in
Google Scholar
PubMed
Search for other papers by Zhenyan Yang in
Google Scholar
PubMed
Search for other papers by Wen Zeng in
Google Scholar
PubMed
Shanghai Yinuo Pharmaceutical Co., Ltd., Shanghai, China
Keenan Research Centre for Biomedical Science, Division of Endocrinology and Metabolism, St. Michael’s Hospital, Toronto, Ontario, Canada
Search for other papers by Qinghua Wang in
Google Scholar
PubMed
Introduction Glucagon-like peptide 1 (GLP-1) is an incretin hormone produced and secreted by intestinal L cells in response to nutrients ingestion. GLP-1 regulates glucose metabolism mainly by stimulating postprandial insulin secretion and
Search for other papers by Akiko Mizokami in
Google Scholar
PubMed
Laboratory of Molecular and Cellular Biochemistry, Faculty of Dental Science, Kyushu University, Fukuoka, Japan
Search for other papers by Satoru Mukai in
Google Scholar
PubMed
Search for other papers by Jing Gao in
Google Scholar
PubMed
Search for other papers by Tomoyo Kawakubo-Yasukochi in
Google Scholar
PubMed
Search for other papers by Takahito Otani in
Google Scholar
PubMed
Search for other papers by Hiroshi Takeuchi in
Google Scholar
PubMed
Laboratory of Molecular and Cellular Biochemistry, Faculty of Dental Science, Kyushu University, Fukuoka, Japan
Search for other papers by Eijiro Jimi in
Google Scholar
PubMed
Search for other papers by Masato Hirata in
Google Scholar
PubMed
et al. 2014 ) or indirectly through stimulation of the secretion of glucagon-like peptide-1 (GLP-1) from intestinal endocrine cells ( Mizokami et al. 2013 , 2014 ). GLP-1 is a member of the incretin family of hormones that are secreted from
Search for other papers by Jonathan D Douros in
Google Scholar
PubMed
Search for other papers by Jacek Mokrosinski in
Google Scholar
PubMed
Search for other papers by Brian Finan in
Google Scholar
PubMed
disadvantageous regulatory mechanisms in a cell-targeted, pathophysiology-specific manner. This review aims to outline the current understanding of signaling bias at the glucagon-like peptide-1 (GLP-1) receptor (GLP-1R) in three broad categories: (i) ligand
Search for other papers by Shin-ya Ueda in
Google Scholar
PubMed
Search for other papers by Takahiro Yoshikawa in
Google Scholar
PubMed
Search for other papers by Yoshihiro Katsura in
Google Scholar
PubMed
Search for other papers by Tatsuya Usui in
Google Scholar
PubMed
Search for other papers by Shigeo Fujimoto in
Google Scholar
PubMed
number of gastrointestinal hormones, such as peptide YY (PYY) and glucagon-like peptide-1 (GLP-1 or GCG as listed in the HUGO Database; Huda et al . 2006 , Näslund & Hellström 2007 , Wren & Bloom 2007 ). PYY is recognized as a satiety factor
Search for other papers by Carmen Sanz in
Google Scholar
PubMed
Search for other papers by Isabel Roncero in
Google Scholar
PubMed
Search for other papers by Patricia Vázquez in
Google Scholar
PubMed
Search for other papers by M Angeles Navas in
Google Scholar
PubMed
Search for other papers by Enrique Blázquez in
Google Scholar
PubMed
glucose concentrations and peptides on GK gene promoter expression was tested in transiently transfected GT1-7 cells. Neither different glucose concentrations (2.8, 5.5, 10, or 20 mM) nor leptin (LEP), glucagon-like peptide 1 (GLP-1) or neuropeptide Y
Search for other papers by Benjamin J Lamont in
Google Scholar
PubMed
Search for other papers by Sofianos Andrikopoulos in
Google Scholar
PubMed
Introduction The incretins glucagon-like peptide 1 (GLP1) and glucose-dependent insulinotropic polypeptide (GIP) act via specific G-protein-coupled receptors to potentiate insulin secretion from pancreatic β-cells in a glucose-dependent manner
Lee Gil Ya Cancer and Diabetes Institute, Department of Endocrinology and Metabolism, Howard Hughes Medical Institute, Gachon Medical Research Institute, Department of Rehabilitation Medicine, College of Pharmacy, Gachon University, 7-45 Songdo‐dong, Yeonsu‐ku, Incheon, Korea
Search for other papers by Yoon Sin Oh in
Google Scholar
PubMed
Search for other papers by Youn-Jung Lee in
Google Scholar
PubMed
Search for other papers by Yup Kang in
Google Scholar
PubMed
Search for other papers by Jaeseok Han in
Google Scholar
PubMed
Search for other papers by Oh-Kyung Lim in
Google Scholar
PubMed
Lee Gil Ya Cancer and Diabetes Institute, Department of Endocrinology and Metabolism, Howard Hughes Medical Institute, Gachon Medical Research Institute, Department of Rehabilitation Medicine, College of Pharmacy, Gachon University, 7-45 Songdo‐dong, Yeonsu‐ku, Incheon, Korea
Search for other papers by Hee-Sook Jun in
Google Scholar
PubMed
-cells and diabetes mellitus . Experimental Biology and Medicine 228 1213 – 1217 . Cunha DA Ladriere L Ortis F Igoillo-Esteve M Gurzov EN Lupi R Marchetti P Eizirik DL Cnop M 2009 Glucagon-like peptide-1 agonists protect pancreatic
Department of Biology, School of Forensic and Investigative Sciences, Hormones Department, School of Pharmacy and Biomedical Sciences, Anatomy, Medical Microbiology, College of Science, United Arab Emirates University, Al-Ain, United Arab Emirates
Department of Biology, School of Forensic and Investigative Sciences, Hormones Department, School of Pharmacy and Biomedical Sciences, Anatomy, Medical Microbiology, College of Science, United Arab Emirates University, Al-Ain, United Arab Emirates
Search for other papers by Mohamed Lotfy in
Google Scholar
PubMed
Department of Biology, School of Forensic and Investigative Sciences, Hormones Department, School of Pharmacy and Biomedical Sciences, Anatomy, Medical Microbiology, College of Science, United Arab Emirates University, Al-Ain, United Arab Emirates
Search for other papers by Jaipaul Singh in
Google Scholar
PubMed
Search for other papers by Hameed Rashed in
Google Scholar
PubMed
Search for other papers by Saeed Tariq in
Google Scholar
PubMed
Search for other papers by Erika Zilahi in
Google Scholar
PubMed
Search for other papers by Ernest Adeghate in
Google Scholar
PubMed
endocrine and an exocrine system with much interaction between the two parts ( Shetzline & Liddle 2002 ). The GI tract secretes a number of hormones including glucose-dependent insulinotropic polypeptide and glucagon-like peptide 1 (GLP1; Drucker 2003 b
Search for other papers by Eun Young Lee in
Google Scholar
PubMed
Search for other papers by Shuji Kaneko in
Google Scholar
PubMed
Search for other papers by Promsuk Jutabha in
Google Scholar
PubMed
Search for other papers by Xilin Zhang in
Google Scholar
PubMed
Search for other papers by Susumu Seino in
Google Scholar
PubMed
Search for other papers by Takahito Jomori in
Google Scholar
PubMed
Search for other papers by Naohiko Anzai in
Google Scholar
PubMed
Search for other papers by Takashi Miki in
Google Scholar
PubMed
Introduction Oral ingestion of nutrients triggers the secretion of gut hormones from various enteroendocrine cells ( Ezcurra et al . 2013 , Cho et al . 2014 ). Among these, glucagon-like peptide 1 (GLP1) and glucose-dependent insulinotropic